AIA
EBS icon

Arcadia Investment Advisors’s Emergent Biosolutions EBS Stock Holding History

Arcadia Investment Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-30
Closed -$311 – 95
2023
Q1 		$311 Hold
30
– – ﹤0.01% 86
2022
Q4 		$355 Hold
30
– – ﹤0.01% 86
2022
Q3 		$630 Hold
30
– – ﹤0.01% 85
2022
Q2 		$931 Hold
30
– – ﹤0.01% 106
2022
Q1 		$1.23K Hold
30
– – ﹤0.01% 106
2021
Q4 		$1.3K Hold
30
– – ﹤0.01% 107
2021
Q3 		$1.5K Hold
30
– – ﹤0.01% 107
2021
Q2 		$1.89K Buy
+30
New +$1.93K ﹤0.01% 121

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arcadia Investment Advisors's EBS Position: Q2 2023 in Review

Arcadia Investment Advisors sold out of Emergent Biosolutions (EBS) in Q2 2023, closing a stake of 30 shares — an estimated $311 sold.

Arcadia Investment Advisors first reported a position in EBS in Q2 2021 and held it in 8 quarters. The position peaked at $1.89K in Q2 2021. 183 funds tracked by Wall St. Rank hold EBS as of Q2 2023.

  • Arcadia Investment Advisors reported no remaining Emergent Biosolutions position as of Q2 2023 after selling out during the quarter.
  • Arcadia Investment Advisors sold 30 Emergent Biosolutions shares in Q2 2023, an estimated $311.
  • Arcadia Investment Advisors first reported a position in Emergent Biosolutions in Q2 2021 and held it in 8 quarters.
  • Arcadia Investment Advisors's Emergent Biosolutions position peaked at $1.89K in Q2 2021.
  • 183 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2023.

Based on Arcadia Investment Advisors's 13F filing for Q2 2023, filed 19 Dec 2024.